These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 17456513

  • 1. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y, Grambsch PM, Neaton JD.
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [Abstract] [Full Text] [Related]

  • 2. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM.
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interim futility analysis with intermediate endpoints.
    Goldman B, LeBlanc M, Crowley J.
    Clin Trials; 2008 Dec; 5(1):14-22. PubMed ID: 18283075
    [Abstract] [Full Text] [Related]

  • 5. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ, Lipsky AM, Berry DA.
    Clin Trials; 2007 Dec; 4(1):5-14. PubMed ID: 17327241
    [Abstract] [Full Text] [Related]

  • 6. Current controversies in data monitoring for clinical trials.
    Pocock SJ.
    Clin Trials; 2006 Dec; 3(6):513-21. PubMed ID: 17170035
    [Abstract] [Full Text] [Related]

  • 7. [Controlled randomized clinical trials].
    Jaillon P.
    Bull Acad Natl Med; 2007 Dec; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [Abstract] [Full Text] [Related]

  • 8. Design and analysis of group sequential clinical trials with multiple primary endpoints.
    Kosorok MR, Yuanjun S, DeMets DL.
    Biometrics; 2004 Mar; 60(1):134-45. PubMed ID: 15032783
    [Abstract] [Full Text] [Related]

  • 9. Frequentist evaluation of group sequential clinical trial designs.
    Emerson SS, Kittelson JM, Gillen DL.
    Stat Med; 2007 Dec 10; 26(28):5047-80. PubMed ID: 17573678
    [Abstract] [Full Text] [Related]

  • 10. [Monitoring the safety of participants in randomised clinical trials: basis and methods].
    Tijssen JG.
    Ned Tijdschr Geneeskd; 2008 Mar 22; 152(12):674-8. PubMed ID: 18438062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM, van der Lee JH, Offringa M.
    Acta Paediatr; 2011 Oct 22; 100(10):1386-92. PubMed ID: 21434998
    [Abstract] [Full Text] [Related]

  • 17. Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm.
    Goldman AI, Hannan PJ.
    Stat Med; 2001 Jun 15; 20(11):1575-89. PubMed ID: 11391689
    [Abstract] [Full Text] [Related]

  • 18. Over-ruling a group sequential boundary--a stopping rule versus a guideline.
    Lan KK, Lachin JM, Bautista O.
    Stat Med; 2003 Nov 15; 22(21):3347-55. PubMed ID: 14566919
    [Abstract] [Full Text] [Related]

  • 19. Power and sample size when multiple endpoints are considered.
    Senn S, Bretz F.
    Pharm Stat; 2007 Nov 15; 6(3):161-70. PubMed ID: 17674404
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.